The current valuation score of Bone Biologics Corp is 8.45, ranking 100 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.73, which is -119.13% below the recent high of 0.14 and -310.21% above the recent low of -3.00.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.